Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP307207.RAm6AZJd_VNICJyId7fy7zlNyLyDAYdjlUs6if0Dee-vw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP307207.RAm6AZJd_VNICJyId7fy7zlNyLyDAYdjlUs6if0Dee-vw130_assertion type Assertion NP307207.RAm6AZJd_VNICJyId7fy7zlNyLyDAYdjlUs6if0Dee-vw130_head.
- NP307207.RAm6AZJd_VNICJyId7fy7zlNyLyDAYdjlUs6if0Dee-vw130_assertion description "[Nearly all tumors lacking activating ras mutations fully regressed following c-MYC deinduction, whereas tumors bearing ras mutations did not, suggesting that secondary mutations in ras contribute to tumor progression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP307207.RAm6AZJd_VNICJyId7fy7zlNyLyDAYdjlUs6if0Dee-vw130_provenance.
- NP307207.RAm6AZJd_VNICJyId7fy7zlNyLyDAYdjlUs6if0Dee-vw130_assertion evidence source_evidence_literature NP307207.RAm6AZJd_VNICJyId7fy7zlNyLyDAYdjlUs6if0Dee-vw130_provenance.
- NP307207.RAm6AZJd_VNICJyId7fy7zlNyLyDAYdjlUs6if0Dee-vw130_assertion SIO_000772 11175856 NP307207.RAm6AZJd_VNICJyId7fy7zlNyLyDAYdjlUs6if0Dee-vw130_provenance.
- NP307207.RAm6AZJd_VNICJyId7fy7zlNyLyDAYdjlUs6if0Dee-vw130_assertion wasDerivedFrom befree-2016 NP307207.RAm6AZJd_VNICJyId7fy7zlNyLyDAYdjlUs6if0Dee-vw130_provenance.
- NP307207.RAm6AZJd_VNICJyId7fy7zlNyLyDAYdjlUs6if0Dee-vw130_assertion wasGeneratedBy ECO_0000203 NP307207.RAm6AZJd_VNICJyId7fy7zlNyLyDAYdjlUs6if0Dee-vw130_provenance.